Alglucerase for Gaucher's disease: dose, costs and benefits.
E
E
Beutler
A M
AM
Garber
D003362:Cost-Benefit Analysis; D004180:Direct Service Costs; D005776:Gaucher Disease / Q000188:drug therapy* / Q000453:epidemiology; D005962:Glucosylceramidase / Q000191:economics / Q000494:pharmacology; D006801:Humans